Search - tctmd.com

Displaying 101 - 120 of 138

Sort: Relevancy | Date

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Daily News

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

August 02, 2012

News Daily News

Según un Análisis del BMJ el uso de la TAVR en Europa Sobrepasa a las Evidencias

August 02, 2012

News Daily News

CREST: Similar Rentabilidad entre la Colocación de Stents Carotídeos y la Cirugía

L.A. McKeown

July 25, 2012

News Daily News

CREST: Similar Cost Effectiveness for Carotid Stenting, Surgery

L.A. McKeown

July 25, 2012

News Daily News

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

July 19, 2012

News Daily News

PARTNER A: La TAVR Transfemoral Mejora la CDV Precoz frente a la Cirugía

July 19, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

News Daily News

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Yael L. Maxwell

July 11, 2012

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

Presentation TVT 2012

Quality-of-Life Measures and Cost-Effectiveness After TAVR

Presenter: David Cohen

June 04, 2012

Presentation TVT 2012

Characterizing Futility from a Quality-of-Life Standpoint: Considerations Beyond Mortality

Presenter: David Cohen

June 04, 2012

News Daily News

TAVR Improves Quality of Life in Clinical Practice

May 01, 2012

News Daily News

La TAVR Mejora la Calidad de Vida en la Práctica Clínica

May 01, 2012

Presentation TCTAP 2012

When is TAVR Not Cost-Effective?

Presenter: David J. Cohen

April 25, 2012

Presentation Fellows 2012

Essentials of Clinical Trial Design

Presenter: David Cohen

April 20, 2012

News Daily News

Carotid Stenting May Be More Costly Than Endarterectomy

L.A. McKeown

April 13, 2012

Advertisement

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

TAVR Use Outstrips Evidence in Europe, BMJ Analysis Says

Según un Análisis del BMJ el uso de la TAVR en Europa Sobrepasa a las Evidencias

CREST: Similar Rentabilidad entre la Colocación de Stents Carotídeos y la Cirugía

CREST: Similar Cost Effectiveness for Carotid Stenting, Surgery

PARTNER A: Transfemoral TAVR Improves Early QOL vs. Surgery

PARTNER A: La TAVR Transfemoral Mejora la CDV Precoz frente a la Cirugía

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Quality-of-Life Measures and Cost-Effectiveness After TAVR

Characterizing Futility from a Quality-of-Life Standpoint: Considerations Beyond Mortality

TAVR Improves Quality of Life in Clinical Practice

La TAVR Mejora la Calidad de Vida en la Práctica Clínica

When is TAVR Not Cost-Effective?

Essentials of Clinical Trial Design

Carotid Stenting May Be More Costly Than Endarterectomy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content